DK385679A - Fremgangsmaade til fremstilling af immunomodulatorer og virumodvirkende midler - Google Patents

Fremgangsmaade til fremstilling af immunomodulatorer og virumodvirkende midler

Info

Publication number
DK385679A
DK385679A DK385679A DK385679A DK385679A DK 385679 A DK385679 A DK 385679A DK 385679 A DK385679 A DK 385679A DK 385679 A DK385679 A DK 385679A DK 385679 A DK385679 A DK 385679A
Authority
DK
Denmark
Prior art keywords
activity
procedure
manufacture
carbon atoms
alkyl
Prior art date
Application number
DK385679A
Other languages
English (en)
Other versions
DK149857B (da
DK149857C (da
Inventor
L N Simon
J W Hadden
Original Assignee
Newport Pharmaceuticals
Sloan Kettering Inst Cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Newport Pharmaceuticals, Sloan Kettering Inst Cancer filed Critical Newport Pharmaceuticals
Publication of DK385679A publication Critical patent/DK385679A/da
Publication of DK149857B publication Critical patent/DK149857B/da
Application granted granted Critical
Publication of DK149857C publication Critical patent/DK149857C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/36—Sulfur atom
    • C07D473/38—Sulfur atom attached in position 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK385679A 1978-09-15 1979-09-14 Analogifremgangsmaade til fremstilling af 9-(2-hydroxyalkyl)-purinsalte DK149857C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94280278 1978-09-15
US05/942,802 US4221909A (en) 1978-09-15 1978-09-15 P-Acetamidobenzoic acid salts of 9-(hydroxyalkyl) purines

Publications (3)

Publication Number Publication Date
DK385679A true DK385679A (da) 1980-03-16
DK149857B DK149857B (da) 1986-10-13
DK149857C DK149857C (da) 1987-03-02

Family

ID=25478620

Family Applications (1)

Application Number Title Priority Date Filing Date
DK385679A DK149857C (da) 1978-09-15 1979-09-14 Analogifremgangsmaade til fremstilling af 9-(2-hydroxyalkyl)-purinsalte

Country Status (27)

Country Link
US (1) US4221909A (da)
EP (1) EP0009154B1 (da)
JP (1) JPS5547683A (da)
KR (1) KR840000552A (da)
AT (1) ATE1949T1 (da)
AU (1) AU527851B2 (da)
CA (1) CA1122217A (da)
CS (1) CS251060B2 (da)
DD (1) DD146049A5 (da)
DE (1) DE2964211D1 (da)
DK (1) DK149857C (da)
ES (1) ES484167A1 (da)
FI (1) FI68234C (da)
GR (1) GR74076B (da)
HU (1) HU182544B (da)
IE (1) IE48827B1 (da)
IL (1) IL58087A (da)
IN (1) IN153099B (da)
MX (1) MX6521E (da)
NO (1) NO152445C (da)
NZ (1) NZ191483A (da)
PH (1) PH16315A (da)
PL (2) PL124515B1 (da)
PT (1) PT70180A (da)
RO (1) RO77565A (da)
YU (1) YU41884B (da)
ZA (1) ZA793973B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4340726A (en) * 1980-03-14 1982-07-20 Newport Pharmaceuticals International, Inc. Esters
US4451478A (en) * 1982-03-12 1984-05-29 Newport Pharmaceuticals International, Inc. Imidazole compounds
US4849411A (en) * 1982-11-09 1989-07-18 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US5147636A (en) * 1982-11-09 1992-09-15 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives and interferons
HUT36464A (en) * 1983-05-24 1985-09-30 Newport Pharmaceuticals Process for producing erythro-4-amino-3-/2-hydroxy-3-alkyl/-imidazol-5-carboxamide
IT1215339B (it) * 1987-01-14 1990-02-08 Co Pharma Corp Srl Procedimento per la preparazione di 9-(idrossialchil)-ipoxantine
US5091432A (en) * 1990-03-28 1992-02-25 Glasky Alvin J 9-substituted hypoxanthine bi-functional compounds and their neuroimmunological methods of use
US5614504A (en) * 1990-08-01 1997-03-25 The University Of South Florida Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
PL318293A1 (en) 1994-07-25 1997-06-09 Alvin J Glasky Carbon monoxide dependent guanilyl cyclase modifiers
WO1997028803A1 (en) * 1996-02-12 1997-08-14 Cypros Pharmaceutical Corporation Hydroxynonyladenine analogs with enhanced lipophilic and anti-ischemic traits
US6303617B1 (en) 1998-05-04 2001-10-16 Neotherapeutics, Inc. Serotonin-like 9-substituted hypoxanthine and methods of use
US6297226B1 (en) 1999-10-15 2001-10-02 Neotherapeutics, Inc. Synthesis and methods of use of 9-substituted guanine derivatives
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) * 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
US6630490B2 (en) 2000-07-07 2003-10-07 Neotherapeutics, Inc. Methods for treatment of disease-induced peripheral neuropathy and related conditions
US6759427B2 (en) * 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
AR046172A1 (es) * 2003-10-03 2005-11-30 3M Innovative Properties Co Pirazolopiridinas y sus analogos; composiciones farmaceuticas que los contienen y su uso en la inhibicion de la biosintesis de citocinas
WO2005074946A1 (en) * 2004-02-10 2005-08-18 Adenobio N.V. Stable and active complexes of adenosine and adenosine phosphates with aminoalcohols for the treatment of pulmonary artery hypertension, cardiac failure and other diseases
USD529397S1 (en) 2004-08-18 2006-10-03 Gabrielle Studio, Inc. Cosmetic container

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3215696A (en) * 1965-11-02 Substituted adenines -and preparation thereof
US3728450A (en) * 1969-08-28 1973-04-17 Newport Pharmaceuticals Inosine derivatives
BE755361A (fr) * 1969-08-28 1971-03-01 Newport Pharmaceuticals Derives de l'inosine
US3857940A (en) * 1971-05-21 1974-12-31 Newport Pharmaceuticals Inosine derivatives
US3836656A (en) * 1972-02-07 1974-09-17 Sandoz Ag Substituted purines as hypolipidemics
US3862189A (en) * 1973-08-14 1975-01-21 Warner Lambert Co Aralkyl-substituted purines and pyrimidines as antianginal bronchodilator agents
US4060616A (en) * 1976-03-01 1977-11-29 Burroughs Wellcome Co. Purine derivatives with repeating unit
YU96177A (en) * 1976-04-24 1982-08-31 Wuelfing Johann A Process for obtaining adenine derivatives

Also Published As

Publication number Publication date
IE791753L (en) 1980-03-15
RO77565A (ro) 1981-11-04
NO152445B (no) 1985-06-24
US4221909A (en) 1980-09-09
NZ191483A (en) 1983-06-14
ES484167A1 (es) 1980-09-01
KR840000552A (ko) 1984-02-25
DK149857B (da) 1986-10-13
FI792849A7 (fi) 1980-03-16
PL119685B1 (en) 1982-01-30
ATE1949T1 (de) 1982-12-15
PH16315A (en) 1983-09-05
EP0009154A1 (en) 1980-04-02
YU41884B (en) 1988-02-29
PL218317A1 (da) 1980-06-16
DE2964211D1 (en) 1983-01-13
EP0009154B1 (en) 1982-12-08
NO152445C (no) 1985-10-02
YU224579A (en) 1983-12-31
DK149857C (da) 1987-03-02
MX6521E (es) 1985-06-27
CS251060B2 (en) 1987-06-11
JPS5547683A (en) 1980-04-04
IL58087A (en) 1983-03-31
IN153099B (da) 1984-06-02
FI68234C (fi) 1985-08-12
IE48827B1 (en) 1985-05-29
JPH031309B2 (da) 1991-01-10
HU182544B (en) 1984-02-28
CA1122217A (en) 1982-04-20
NO792792L (no) 1980-03-18
DD146049A5 (de) 1981-01-21
PT70180A (en) 1979-10-01
ZA793973B (en) 1980-09-24
GR74076B (da) 1984-06-06
FI68234B (fi) 1985-04-30
AU5055779A (en) 1980-03-20
AU527851B2 (en) 1983-03-24
PL124515B1 (en) 1983-01-31

Similar Documents

Publication Publication Date Title
AU527851B2 (en) Purine derivatives
ES527954A1 (es) Un procedimiento para preparar isoxazoles
FI823923A0 (fi) Antifibrinolytiskt aktiva foereningar
IL69292A (en) Muramyl peptides substituted by 1,2-diacylated-sn-glycero-3-hydroxyphosphoryl,their manufacture and pharmaceutical compositions containing them
AU3429784A (en) Use of quinoline derivatives for the protection of cultivated plants
ES494263A0 (es) Un procedimiento de preparacion de pirido-indoles
DK440987A (da) Thyroninderivater, deres fremstilling og anvendelse
SE7903336L (sv) N-alkenylmoranolin-derivat
EP0481370A3 (en) Use of phosphonic acid diglycidylesters as cross-linking agent in hydrogels
ES455841A1 (es) Procedimiento para preparar composiciones insecticidas a ba-se de ditiofo-fatos-(-fonatos) de formamidina.
SE9000809L (sv) Komposition foer att foerbaettra kompatibiliteten foer vaetskeformiga konstgoedselmedel med vaextskyddsmedel
SE8302972L (sv) Nya karbamidkompositioner
ES8107202A1 (es) Procedimiento para preparar nuevos derivados de oxadiazolin-1,3,4-ona-5.
GB2022075A (en) Lactam-N-acetic acids and the preparation thereof
ES472090A2 (es) Mejoras introducidas en el objeto de la patente principal n.451407 por:procedimiento para preparar derivados de amidoxi-ma

Legal Events

Date Code Title Description
PBP Patent lapsed